Business Context and Reporting Period
This Form 6-K filing is submitted by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in request metadata) for the month of June 2018. The registrant is a foreign private issuer based in the United Kingdom. The filing serves to incorporate by reference two press releases dated June 1, 2018: the "2017 Annual Report and AGM Notification" and a "Board Change" announcement.
Key Financial Metrics
The provided text contains only the cover page and exhibit list of the Form 6-K. It does not include the full text of the 2017 Annual Report or the specific press releases. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing indicates a Board Change occurred as of June 1, 2018. No specific financial material changes versus prior periods are detailed in the provided text.
Guidance, Outlook, and Risks
The filing references an Annual Report and AGM notification, which typically contain management commentary and outlook, but the specific content of these documents is not included in the input text. Therefore, no guidance, risks, or contingencies can be summarized from the provided source.
Investor Verification Checklist
- Verify the specific details of the Board Change referenced in Exhibit 99.2.
- Review the full 2017 Annual Report (Exhibit 99.1) for actual financial performance data, as it is not present in this summary text.
- Confirm the identity of the registrant, as the request metadata lists "Biodexa Pharmaceuticals Plc" while the filing explicitly names "Midatech Pharma PLC."